GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma is an aggressive cancer. We investigated genetic response predictors for patients with advanced esophageal squamous cell carcinoma receiving concurrent chemoradiotherapy. A cohort of 108 patients was recruited. Survival analysis showed that lower esophageal locatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsou, Yung-Kuan, Liang, Kung-Hao, Lin, Wey-Ran, Chang, Hsien-Kun, Tseng, Chen-Kan, Yeh, Chau-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438720/
https://www.ncbi.nlm.nih.gov/pubmed/28418863
http://dx.doi.org/10.18632/oncotarget.16253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438720/
https://www.ncbi.nlm.nih.gov/pubmed/28418863
http://dx.doi.org/10.18632/oncotarget.16253

Ejemplares similares